MLYSMineralys Therapeutics, Inc.
$23.36-41% 1Y
$23.36
$21.9552 weeks$47.33
The financials
Mineralys Therapeutics, Inc. by the numbers
The next results filing is expected around Nov 9, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Operating income | −$246M | −$47M | n/a |
| Net income | −$241M | −$43M | n/a |
| Diluted EPS | −$2.85 | −$0.66 | n/a |
On our screens:Most shorted stocks